Braveheart Bio, Inc. (BRVE)
Latest BRVE Insider Trades
About Braveheart Bio, Inc. (BRVE)
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).
- SAN FRANCISCO, CA
- 2026
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 13 | 8,835,275 | $159.03M |
| Grant or award | 9 | 1,360,000 | |
| Other acquisition / disposition | 12 | 279,440,638 |
BRVE Insider Transactions (Form 4)
3414 Form 4 filings on record, the earliest from Aug 7, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| AH Bio Fund IV, L.P. - 10% Owner | Other | Common Stock | 9,132,420 |
Recent BRVE Form 8-K Filings
2BRVE Insider Trading - FAQ
What is the latest insider trade for BRVE?
Braveheart Bio, Inc. (BRVE) had 14 insider filings in the last 90 days, with the most recent on 2026-08-11. The full record for BRVE runs to 14 Form 4 filings, the earliest from 2026-08-07. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying BRVE stock?
13 insider purchases of BRVE were filed in the last 90 days, totaling $159.03M.
How many insiders are selling BRVE stock?
No insider sales of BRVE were filed in the last 90 days.
Where can I see BRVE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks BRVE Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow BRVE insider buys?
Create a free InsiderAlpha account and press Watch on this page to add BRVE to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - AH Bio Fund IV, L.P. view on EDGAR
- - Erez Chimovits view on EDGAR
- - ORBIMED ADVISORS LLC view on EDGAR
- - Jiangsu Hengrui Pharmaceuticals Co., Ltd. view on EDGAR
- - Forbion Growth Opportunities Fund III Cooperatief U.A. view on EDGAR
- - James Paul Rickey view on EDGAR
- - Tim Lohoff view on EDGAR
- - Erez Chimovits view on EDGAR
- - Christopher Viehbacher view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where BRVE's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track BRVE insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
